Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

9 results
Display

Evolution of Radiological Treatment Response Assessments for Cancer Immunotherapy: From iRECIST to Radiomics and Artificial Intelligence

Kim N, Lee ES, Won SE, Yang M, Lee AJ, Shin Y, Ko Y, Pyo J, Park HJ, Kim KW

Immunotherapy has revolutionized and opened a new paradigm for cancer treatment. In the era of immunotherapy and molecular targeted therapy, precision medicine has gained emphasis, and an early response assessment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Radiological Tumor Response Based on iRECIST and RECIST 1.1 in Metastatic Clear-Cell Renal Cell Carcinoma Patients Treated with Programmed Cell Death-1 Inhibitor Therapy

Zheng B, Shin JH, Li H, Chen Y, Guo Y, Wang M

Objective: To evaluate the radiological tumor response patterns and compare the response assessments based on immunebased therapeutics Response Evaluation Criteria in Solid Tumors (iRECIST) and RECIST 1.1 in metastatic clear-cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of RECIST, PERCIST, EORTC, and MDA Criteria for Assessing Treatment Response with Ga68-PSMA PET-CT in Metastatic Prostate Cancer Patient with Biochemical Progression: a Comparative Study

Gupta M, Choudhury , Rawal S, Goel HC, Rao SA

PURPOSE: The aim of the study was to compare response evaluation criteria in solid tumours 1.1 (RECIST 1.1), positron emission tomography response criteria in solid tumours (PERCIST), European organisation for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimal Phase of Dynamic Computed Tomography for Reliable Size Measurement of Metastatic Neuroendocrine Tumors of the Liver: Comparison between Pre- and Post-Contrast Phases

Huh J, Park J, Kim KW, Kim HJ, Lee JS, Lee JH, Jeong YK, Shinagare , Ramaiya NH

OBJECTIVE: The reliability of size measurements of liver metastases from neuroendocrine tumors (NETs) on contrast-enhanced computed tomography (CT) phases made by different readers may be hampered due to transient, variable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Maximum diameter versus volumetric assessment for the response evaluation of vestibular schwannomas receiving stereotactic radiotherapy

Choi Y, Kim S, Kwak DW, Lee HS, Kang MK, Lee DK, Hur WJ

PURPOSE: To explore the feasibility of maximum diameter as a response assessment method for vestibular schwannomas (VS) after stereotactic radiosurgery or fractionated stereotactic radiotherapy (RT), we analyzed the concordance of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tumor Response Evaluation after Treatment and Post-treatment Surveillance of Hepatocellular Carcinoma

Yoon JS, Park SY

Hepatocellular carcinoma is one of the most prevalent malignancies and frequent causes of death worldwide. Treatment options of hepatocellular carcinoma consist of locoregional therapy, surgical resection, liver transplantation, and systemic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer

Kim S, Oh SW, Kim JS, Kim KH, Kim YK

PURPOSE: To evaluate the predictive value of the early response of 18F-flurodeoxyglucose positron emission tomography (FDG PET) during concurrent chemoradiotherapy (CCRT) for locally advanced non-small cell lung cancer (NSCLC). MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
RECIST Criteria for Tumor Response in the Patients with Breast Cancer Who Had Neoadjuvant Chemotherapy

Lee JC, Bae JS, Kim MR, Park WC, Song BJ, Kim JS, Jung SS

  • KMID: 2145065
  • J Korean Surg Soc.
  • 2007 Feb;72(2):89-93.
PURPOSE: This study compared the response evaluation using the WHO (World Health Organization) criteria for patients with breast cancer with that of the RECIST (Response Evaluation Criteria In Solid Tumor)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of WHO and RECIST Criteria for Response in Metastatic Colorectal Carcinoma

Choi JH, Ahn MJ, Rhim HC, Kim JW, Lee GH, Lee YY, Kim IS

  • KMID: 2166118
  • Cancer Res Treat.
  • 2005 Oct;37(5):290-293.
PURPOSE: This study compared the WHO criteria with the response evaluation criteria in solid tumors (RECIST) in the same patients with metastatic colorectal cancer in order to determine the significance...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr